Terrie Kellmeyer, PhD
Equibles does not estimate personal net worth.
Get an email with a short summary when Anavex Life Sciences Corp. publishes a filing, an earnings call transcript or a press release.
Get AVXL alertsAbout Terrie Kellmeyer, PhD
Terrie Kellmeyer, PhD is recorded as CEO at Anavex Life Sciences Corp. (AVXL) since May 4, 2026. Anavex Life Sciences Corp. reported in an 8-K filed May 6, 2026 that Terrie Kellmeyer, PhD was appointed Interim Chief Executive Officer, effective May 4, 2026. Anavex Life Sciences Corp. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Anavex Life Sciences Corp. includes Athanasios Skarpelos (Board Member), Axel Paeger (Board Member), Christopher Missling, PhD (Board Member) and 4 others.
“On May 4, 2026, the Board appointed Terrie Kellmeyer, PhD as the Company's Interim Chief Executive Officer.”
Affiliation history
-
Current
2026-05-04–present
Company network
Leadership on record at Anavex Life Sciences Corp.
- Athanasios Skarpelos Board Member
- Axel Paeger Board Member
- Christopher Missling, PhD Board Member
- Claus van der Velden, PhD Board Member
- Jiong Ma, PhD Board Member
- Peter Donhauser, D.O. Board Member
- Steffen Thomas, PhD Board Member